Hodgkin lymphoma in very young children: Clinical characteristics and outcome of treatment

Leukemia and Lymphoma

Volumn 49, Issue 5, 2008, Pages 910-916

  Belgaumi, Asim ^a   Al Kofide, Amani ^a   Joseph, Nicey ^a   Jamil Malik, Rubina ^a   Khafaga, Yasser ^a   Sabbah, Rajeh ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Chemotherapy; Childhood; Hodgkin lymphoma; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ADOLESCENT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; HEART DISEASE; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; LUNG TOXICITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE; SHOCK; SURVIVAL TIME; TREATMENT RESPONSE; UTERINE CERVIX DISEASE; VITILIGO;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 46749114044     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190801947492     Document Type: Article

References (21)

1. Clavel, J., Steliarova-Foucher, E., Berger, C., Danon, S. and Valerianova, Z. (2006) Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): Report from the Automated Cancer Information System project. Eur J Cancer, 42, pp. 2037-2049.
2. Gruffermann, S. and Delzell, E. (1984) Epidemiology of Hodgkin Disease. Epidemiol Rev, 6, pp. 76-106.
3. Dinand, V. and Arya, L. S. (2006) Epidemiology of childhood Hodgkin's disease: Is it Different in developing countries?. Indian Pediatr, 43, pp. 141-147.
4. Siddiqui, N., Ayub, B., Badar, F. and Zaidi, A. (2006) Hodgkin's lymphoma in Pakistan: A clinico-epidemiological study of 658 cases at a cancer center in Lahore. Asian Pac J Cancer Prev, 7, pp. 651-655.
5. Stiller, C. A. and Parkin, D. M. (1990) International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol, 4, pp. 303-324.
6. Kusuda, M., Toriyama, K., Kamidigo, N. O. and Itakura, H. (1998) A comparison of epidemiologic, histologic and virologic studies on Hodgkin's disease in Western Kenya and Nagasaki, Japan. Am J Trop Hyg, 59, pp. 801-817.
7. Karimi, M., Yarmohammadi, H., Ghavanini, A. A. and Kumar, P. V. (2002) Epidemiological surveillance of pediatric Hodgkin's disease in Southern Iran. Med Sci Monit, 8, pp. CR572-CR575.
8. Macfarlane, G. J., Evstifeeva, T., Boyle, P. and Grufferman, S. (1995) International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer, 61, pp. 165-169.
9. Buyukpamukcu, M., Atahan, L., Caglar, M., Kutluk, T., Akyuz, C. and Hazar, V. (1999) Hodgkin's disease in Turkish children: Clinical characteristics and treatment results of 210 patients. Pediatr Hematol Oncol, 16, pp. 119-129.
10. Schwartz, C. L. (2003) The management of Hodgkin disease in the young child. Curr Opin Pediatr, 15, pp. 10-16.
11. Chow, L ML, Nathan, P. C., Hodgson, D. C., Jenkin, D., Weitzman, S. and Grant, R. M. (2006) Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. J Clin Oncol, 24, pp. 5735-5741.
12. Kung, F. H. (1991) Hodgkin's disease in children 4 years of age or younger. Cancer, 67, pp. 1428-1430.
13. Stoneham, S., Ashley, S., Pinkerton, R., Hewitt, M., Wallace, W HB and Shankar, A. G. (2007) Hodgkin lymphoma in children aged 5 years or less - the United Kingdom experience. Eur J Cancer, 43, pp. 1415-1421.
14. Grufferman, S. and Delzell, E. (1984) Epidemiology of Hodgkin's disease. Epidemiologic Rev, 6, pp. 76-106.
15. Parkin, D. M., Stiller, C. A., Draper, G. J. and Bieber, C. A. (1988) The International incidence of childhood cancer. Int J Cancer, 42, pp. 511-520.
16. Yadav, M. S., Malliga, N. and Ablashi, D. V. (1987) Development of immunity to Epstein - Barr virus in Malaysian children. Microbiologica, 10, pp. 29-35.
17. Chan, C. W., Chiang, A KS, Chan, K. H. and Lau, A SY (2003) Epstein - Barr virus-associated infectious mononucleosis in Chinese children. Pediatr Infect Dis J, 22, pp. 974-978.
18. Murray, P. G., Billingham, L. J., Hassan, H. T., Flavell, J. R., Nelson, P. N. and Scott, K. (1999) Effect of Epstein - Barr virus on the response to chemotherapy and survival in Hodgkin's disease. Blood, 94, pp. 442-447.
19. Engel, M., Essop, M. F., Close, P., Hartley, P., Pallesen, G. and Sinclair-Smith, C. (2000) Improved prognosis on Epstein - Barr virus associated childhood Hodgkin's lymphoma: Study of 47 South African cases. J Clin Pathol, 53, pp. 182-186.
20. Alebouyeh, M., Moussavi, F., Haddad-Deylami, H. and Vossough, P. (2005) Successful ambulatory treatment of Hodgkin's disease in Iranian children based on German-Austrian DAL-HD 85-90: Single institution results. Ann Oncol, 16, pp. 1936-1940.
21. Hsu, S. C., Metzger, M. L., Hudson, M. M., Pedrosa, F., Lins, M. and Pedrosa, M. (2007) Comparison on treatment outcomes on childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Pediatr Blood Cancer, 49, pp. 139-144.